Complementary Use of Carbohydrate Antigens Lewis a, Lewis b, and Sialyl-Lewis a (CA19.9 Epitope) in Gastrointestinal Cancers: Biological Rationale towards a Personalized Clinical Application

Carbohydrate antigen 19.9 (CA19.9) is used as a tumor marker for clinical and research purposes assuming that it is abundantly produced by gastrointestinal cancer cells due to a cancer-associated aberrant glycosylation favoring its synthesis. Recent data has instead suggested a different picture, wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Indellicato, Rossella, Zulueta, Aida, Caretti, Anna, Trinchera, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352550/
https://www.ncbi.nlm.nih.gov/pubmed/32527016
http://dx.doi.org/10.3390/cancers12061509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352550/
https://www.ncbi.nlm.nih.gov/pubmed/32527016
http://dx.doi.org/10.3390/cancers12061509

Ejemplares similares